Analysis of serum levels and DNA methylation of fibroblast growth factor 21 using peripheral blood-derived genomes in patients with obesity
Fibroblast growth factor (FGF) 21, a hormone produced by the liver, improves glucose and lipid metabolism. We recently demonstrated that the FGF21 gene (Fgf21) underwent DNA demethylation in the mouse liver via peroxisome proliferator-activated receptor (PPAR) α during the fetal to lactation periods...
Saved in:
Main Authors: | Hiroyuki Shinozaki, Shiori Kawai, Mami Gamo-Kawasaki, Ayano Takei, Kyoko Tsujikado, Kazunori Fukuda, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Kohzo Takebayashi, Koshi Hashimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2024-09-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/71/9/71_EJ23-0570/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity
by: Kenji Hara, et al.
Published: (2024-01-01) -
FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review
by: Hajime Kato, et al.
Published: (2023-10-01) -
Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
by: Masahiro Kikuchi, et al.
Published: (2024-09-01) -
Genes related to neural tube defects and glioblastoma
by: Rui Cao, et al.
Published: (2025-01-01) -
Pharmacological effects of fibroblast growth factor 21 are sex-specific in mice with the <em>lethal yellow</em> (A<sup>y</sup>) mutation
by: E. N. Makarova, et al.
Published: (2020-04-01)